A Literature Review of Laboratory-Acquired Brucellosis

被引:113
|
作者
Traxler, Rita M. [1 ]
Lehman, Mark W. [1 ,2 ]
Bosserman, Elizabeth A. [1 ]
Guerra, Marta A. [1 ]
Smith, Theresa L. [1 ]
机构
[1] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA
关键词
BRITISH CLINICAL LABORATORIES; OCCUPATIONAL HAZARD; MELITENSIS; INFECTIONS; OUTBREAK; DISEASE; TRANSMISSION; EXPOSURE; WORKERS; FEVER;
D O I
10.1128/JCM.00135-13
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Brucellosis is a bacterial zoonotic disease which has been associated with laboratory-acquired infections. No recent reviews have addressed the characteristics of laboratory-acquired brucellosis (LAB). English-language literature was reviewed to identify reports of laboratory exposures to Brucella spp. and LAB cases between 1982 and 2007. Evaluation of 28 case reports identified 167 potentially exposed laboratory workers, of whom 71 had LAB. Nine reports were identified that summarized an additional 186 cases of LAB. Only 18 (11%) exposures were due to laboratory accidents, 147 (88%) exposures were due to aerosolization of organisms during routine identification activities, and the circumstances of 2 (1%) exposures were unknown. Brucella melitensis was the causative agent in 80% (135/167) of the exposures. Workers with high-risk exposures were 9.3 times more likely to develop LAB than workers with low-risk exposures (95% confidence interval [CI], 3.0 to 38.6; P < 0.0001); they were also 0.009 times likelier to develop LAB if they took antimicrobial PEP than if they did not (95% CI, 0 to 0.042; P < 0.0001). The median incubation period in case and summary reports was 8 weeks (range 1 to 40 weeks). Antimicrobial PEP is effective in preventing LAB. The incubation period may be used to identify appropriate serological and symptom surveillance time frames for exposed laboratory workers.
引用
收藏
页码:3055 / 3062
页数:8
相关论文
共 50 条
  • [21] LABORATORY-ACQUIRED INFECTIONS
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1951, 147 (15): : 1456 - 1457
  • [22] LABORATORY-ACQUIRED HISTOPLASMOSIS
    MURRAY, JF
    HOWARD, D
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1964, 89 (05): : 631 - &
  • [23] LABORATORY-ACQUIRED SPOROTRICHOSIS
    COOPER, CR
    DIXON, DM
    SALKIN, IF
    JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY, 1992, 30 (02): : 169 - 171
  • [24] LABORATORY-ACQUIRED TUBERCULOSIS
    PEERBOOMS, PGH
    VANDOORNUM, GJJ
    VANDEUTEKOM, H
    COUTINHO, RA
    VANSOOLINGEN, D
    LANCET, 1995, 345 (8960): : 1311 - 1312
  • [25] LABORATORY-ACQUIRED INFECTIONS
    SULKIN, SE
    BACTERIOLOGICAL REVIEWS, 1961, 25 (03) : 203 - +
  • [26] LABORATORY-ACQUIRED HISTOPLASMOSIS
    SPICKNALL, CG
    RYAN, RW
    CAIN, A
    NEW ENGLAND JOURNAL OF MEDICINE, 1956, 254 (05): : 210 - 214
  • [27] LABORATORY-ACQUIRED INFECTIONS
    SULKIN, SE
    PIKE, RM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1951, 147 (18): : 1740 - 1745
  • [28] LABORATORY-ACQUIRED MYCOBACTERIAL INFECTION
    MULLER, HE
    LANCET, 1988, 2 (8606): : 331 - 331
  • [29] Laboratory-acquired VTEC infection
    Phillips, G
    Old, DC
    JOURNAL OF HOSPITAL INFECTION, 1997, 35 (01) : 72 - 72
  • [30] LABORATORY-ACQUIRED GONOCOCCAL CONJUNCTIVITIS
    BRUINS, SC
    TIGHT, RR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 241 (03): : 274 - 274